disease state plasma newsflash - august 2014 - bbi solutions

13
Inventory Newsflash August 2014 New Products Disease State Plasma Capabilities New Inventory Clinical Samples Capabilities New Inventory Specialty blood products Capabilities Inventory correct at time of publication

Upload: bbisolutions

Post on 18-Dec-2014

734 views

Category:

Health & Medicine


4 download

DESCRIPTION

In this month’s newsflash view our latest inventory of autoimmune, infectious disease and ethically approved disease state plasma units. You can also find out about our ethics approval scheme and our speciality blood products.

TRANSCRIPT

Page 1: Disease State Plasma Newsflash - August 2014 - BBI Solutions

Inventory Newsflash August 2014

New Products

Disease State PlasmaCapabilities

New Inventory

Clinical SamplesCapabilities

New Inventory

Specialty blood productsCapabilities

Inventory correct at time of publication

Page 2: Disease State Plasma Newsflash - August 2014 - BBI Solutions

Save time and optimise your success rate by selecting from our highly characterised disease state plasma units.

Have confidence in supply sustainability and traceability by choosing a trusted partner with global collections directly from hospitals and blood banks.

Representative set of samples – we have rare materials from early disease diagnosis available, stored at a HTA licenced facility.

Many of our disease state plasma, samples and remnant materials are collected with ethics approval and donor consent when relevant.

Why choose BBI ?

Quick Links

Latest news >New Product >

Disease State PlasmaOur Capabilities >New Inventory Items >

Clinical SamplesOur Capabilities >New Inventory Items >

Speciality BloodOur Capabilities >

How to order >

Page 3: Disease State Plasma Newsflash - August 2014 - BBI Solutions

Latest News

Ethics approval / IRB recently granted for our following infectious disease plasma units:

HIV HBV HCV Syphilis

Increased inventory levels, and an improved turnaround time on our screening programs taking place at both our UK and South African facilities.

Ethics approval – key facts

Specimen donors participate voluntarily and give prior informed consent in accordance with local regulations and practices.

Ethics approval / IRB is a mandatory FDA requirement for 510k submission for a new diagnostic device.

Remnant samples are often exempt from consenting process when delinked from patient / donor identifiable data.

Many of our patient samples have ethics approval / IRB.

Page 4: Disease State Plasma Newsflash - August 2014 - BBI Solutions

Infectious Disease Autoimmune Cardiac

Chlamydia IgG / IgM Anti-GBM Cholesterol

CMV IgG / IgM / Negative Anti-RNP / Anti-SSA HDL

EBV IgG / IgM ANCA (Anti-MPO / Anti-PR3) Hypertension

H. Pylori Celiac Disease LDL

HAV IgG / IgM Crohn’s Disease Triglyceride

HCV IgG Gliadin Antibodies IgA / IgG

HBsAg HAMA Organ Failure / Impairment

HBc IgM / Total Ab Rheumatoid Factor Renal Failure

HBeAg / HBeAb SLE / dsDNA Ab Kidney Transplant

HIV 1 Tissue Transglutaminase Abs Liver Transplant

HIV 2 Anti-CCP Negative - NEW

HIV O Intrinsic Factor Ab – NEW Diabetes

HSV 2 IgG / IgM VGKC Ab - NEW Glucose

HTLV-1 HbA1c

HTLV-2 Autoimmune Thyroid Disease Diagnosis (Type I / II)

HEV Anti-Tg

Lyme IgG / IgM Anti-TPO Pregnancy

Malaria Graves Disease Amniotic Fluid

Parvovirus B19 Hashimoto’s Disease Pregnancy Serum

Rubella IgG / Negative Chronological Bulk Urine

Rubella IgM – NEW Inflammation / Allergy

Syphilis IgG / IgM CRP Other Biomaterials

Toxoplasma IgG / IgM / Negative SAA CSF

Specific IgE (Allergy) Urine

Biochemistry Saliva

Vitamin D Drugs of Abuse Cord Serum

CDT

Our Capabilities: Disease State Plasma

Page 5: Disease State Plasma Newsflash - August 2014 - BBI Solutions

New Inventory: Disease State Plasma

Autoimmune Disease

Biomarker Product CodeQuantitative

resultsVolume available

in stock (ml)Collection

Method

FDA Tested Negative for other virals

Serum Amyloid A SH127-3 Yes >5,000 ml Apheresis Yes

Voltage Gated Potassium Channel Ab

SH128-3 Yes >2,500 ml Apheresis Yes

p-ANCA (MPO) Ab SH152-3 Yes >9,000 ml Apheresis Yes

dsDNA Ab SH237-3 Yes >2,500 ml Apheresis Yes

Intrinsic Factor Ab SH448-3 Yes >3,000 ml Apheresis Yes

Anti-CCP Negative SH159-3 Yes >11,000 ml Apheresis Yes

Page 6: Disease State Plasma Newsflash - August 2014 - BBI Solutions

New Inventory: Disease State Plasma

Disease Type

Product CodeQuantitative

results & other markers Tested

Volume available in stock (ml)

Collection Method

FDA Tested Negative for other virals

Rubella IgM SH252-9 Rubella IgM >6,000 ml Synthetic Matrix Yes

Hepatitis E SH264-4 Viral Load / Serology / Genotype

~200 ml Recovered Yes

HAV SH265-4 S/CO Ratio >5 ~1,500 ml Apheresis Yes

Infectious Disease

Ethically Approved

Disease Type

Product CodeQuantitative

results & other markers Tested

Volume available in stock (ml)

Collection Method

FDA Tested Negative for other virals

Syphilis SH266-4 RPR / TPHA > 6,000 ml Recovered Yes

HCV SH259-4 Viral Load / Serology / Genotype

> 1,500 ml Recovered Yes

Page 7: Disease State Plasma Newsflash - August 2014 - BBI Solutions

“Our synthetic rubella IgM serum is an

economical alternative to native serum”

New Product: Synthetic Rubella IgM Serum

What is synthetic rubella IgM serum?

A human monoclonal rubella IgM antibody formulated in a delipidated, defibrinated plasma.

Why do we need it?

Native disease state plasma is used in the manufacture of controls and calibrators. However, since most people are vaccinated for rubella at a young age it is very difficult to source a native plasma.  Our synthetic rubella IgM serum is a great alternative to native disease state plasma for the consistent manufacture of controls and calibrators.

Page 8: Disease State Plasma Newsflash - August 2014 - BBI Solutions

Our results demonstrate that synthetic rubella IgM serum is comparable with a native sample, and has excellent batch to batch consistency across a dynamic range.

Proven performance on the top commercial testing platforms

0 1 2 3 4 5 6 7 8 9 100

4

8

12

16

20Abbott Architect

Batch 1

Batch 2

Batch 3

Positive Control

Negative controlDilution Factor

s/co

In

dex

Val

ue

0 1 2 3 4 5 6 7 8 9 10048

121620

Siemens Immulite

Batch 1

Batch 2

Batch 3

Positive Control

Negative controlDilution Factor

s/co

In

dex

Val

ue

0 1 2 3 4 5 6 7 8 9 10048

121620

Roche COBAS

Batch 1

Batch 2

Batch 3

Positive Control

Negative controlDilution Factor

s/co

In

dex

Val

ue

0 1 2 3 4 5 6 7 8 9 10048

121620

BioMerieux VIDAS

Batch 1

Batch 2

Batch 3

Positive Control

Negative controlDilution Factors/

co I

nd

ex V

alu

e

Page 9: Disease State Plasma Newsflash - August 2014 - BBI Solutions

Why use this product in your next control?

Eliminate the supply issues often faced when sourcing rare native rubella IgM serum

Have confidence in a product with proven performance across various commercial platforms

Ensure correct results every time with no batch to batch variations

Use a product with a high efficacy to the disease, eliminating the need for infected donors.

Eliminate false positives with a product with that has been proven to not detect IgG

 

Order your evaluation sample today 

[email protected] or +44 (0) 2920 767 499 

Page 10: Disease State Plasma Newsflash - August 2014 - BBI Solutions

Our Capabilities: Clinical Samples

Infectious Disease Autoimmune Thyroid DiabetesChlamydia pneumoniae IgA/IgG ASO Free T3 (Triiodothyronine) HbA1cChlamydia trachomatis IgA/IgG Anti-Cardiolipin Free T4 (Thyroxine) Diagnosis (Type I / II)CMV IgG / IgM / Negative Anti-CCP Parathyroid Hormone (PTH)EBV Anti-dsDNA TSH Organ Failure/ImpairmentHCV IgG Anti-GBM Renal FailureHBsAg / Anti-HBs Anti-Nuclear Antibodies (Includes: Pregnancy Hepatic ImpairmentHBc IgM / Total Ab SS-A/Ro, SS-B/La, Sm, RNP hCGHBeAg / HBeAb Jo-1, PM-SCL, KU, Centromere, Pre-eclampsia OncologyHEV AMA-M2, RIB-P, RO52) Pregnancy serum AFPHIV 1 / 2 / O Anti-Tg CA 125HTLV-1 / HTLV-2 Anti-TPO Cardiac CA 15-3Malaria ANCA (Anti-MPO / Anti-PR3) Cholesterol CA 19-9Measles IgG Celiac Disease CK-MB CEAMycoplasma pneumoniae Crohn’s Disease D Dimer CYFRAParvovirus B19 Gliadin Antibodies IgA / IgG HDL PSA

Rubella IgM / IgG / Negative HAMA HypertensionSepsis Histone Antibodies LDL EndocrineSyphilis IgG / IgM Rheumatoid Factor Myoglobin CortisolToxo IgG / IgM / Negative SLE NT proBNP FSHYersinia IgG / IgM Tissue Transglutaminase Abs Triglyceride LH

Troponin I Oestradiol

Biochemistry Neurological ProgesteroneVitamin D Alzheimer’s Disease Drugs of Abuse ProlactinBilirubin (Total) NSE Urine SHBG

Calcium CDT Testosterone

Potassium Allergy

CRP Raised Specific IgE

Page 11: Disease State Plasma Newsflash - August 2014 - BBI Solutions

New Inventory: Clinical Samples

Code No. Marker Category Panel Type Matrix

SG338-2 Toxoplasma IgG ToRCH Positive Serum

SG340-2 Toxoplasma IgM ToRCH Positive Serum

SG342-2 CMV IgG ToRCH Positive Serum

SG350-2 Rubella IgG ToRCH Positive Serum

SG352-2 Rubella IgM ToRCH Positive Serum

Infectious Disease Panels

Supplied with . . .

Age Gender Draw date Testing method

Page 12: Disease State Plasma Newsflash - August 2014 - BBI Solutions

Our Capabilities: Specialty Blood Products

Normal serum and plasma and

speciality products in a variety of

anticoagulants.

Range of volume from 1ml to full single

serum / plasma units.

Large scale collections possible

>1,000 L.

Custom control of the pre-analytical

phase available.

Custom Plasma collection in FDA licensed facilities

Custom anticoagulant, capabilities of >500L per month.

“Packed” red cells

Available in bulk in K3-EDTA.

Page 13: Disease State Plasma Newsflash - August 2014 - BBI Solutions

How to Order

[email protected]

USA: 1-800-423-8199

Intl: +44 (0) 2920 747 232

Quote NFAUG on ordering

Please get in touch to arrange a quote for any of our products.

If you can’t find what you are looking for, take a look at some of our customised services:

Custom collections

Pooling service

Custom testing / screening

Custom specifications for products

requiring regular supply for production